Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
3.490
-0.080 (-2.24%)
At close: Dec 5, 2025, 4:00 PM EST
3.620
+0.130 (3.72%)
After-hours: Dec 5, 2025, 7:32 PM EST
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 8 employees as of March 31, 2025. The number of employees decreased by 2 or -20.00% compared to the previous year.
Employees
8
Change (1Y)
-2
Growth (1Y)
-20.00%
Revenue / Employee
$2,117,125
Profits / Employee
-$434,875
Market Cap
5.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNOA News
- 23 days ago - National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results - Accesswire
- 7 weeks ago - Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA - Accesswire
- 2 months ago - Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 - Accesswire
- 3 months ago - National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced - Accesswire
- 4 months ago - Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains - Accesswire